Aarushi Lithotripsy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.11 M
as on 24-10-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.55 M
as on 24-10-2024
- Revenue 18.26%
(FY 2023)
- Profit 36.65%
(FY 2023)
- Ebitda -1811.91%
(FY 2023)
- Net Worth -91.38%
(FY 2023)
- Total Assets -25.03%
(FY 2023)
About Aarushi Lithotripsy
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹5.55 M.
Lakshmi Priya, Keshvarmurthy Mohan, and Sreenivasa Raju serve as directors at the Company.
- CIN/LLPIN
U85110KA2005PTC036093
- Company No.
036093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aarushi Lithotripsy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Priya  | Whole-Time Director | 10-Jul-2014 | Current |
| Keshvarmurthy Mohan | Whole-Time Director | 18-Apr-2005 | Current |
| Sreenivasa Raju | Whole-Time Director | 18-Apr-2005 | Current |
Financial Performance and Corporate Structure Insights of Aarushi Lithotripsy.
Aarushi Lithotripsy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.26% increase. The company also saw a substantial improvement in profitability, with a 36.65% increase in profit. The company's net worth observed a substantial decline by a decrease of 91.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarushi Lithotripsy?
In 2023, Aarushi Lithotripsy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lalitha Healthcare Private LimitedActive 19 years 9 monthsLakshmi Priya and Sreenivasa Raju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 15 Dec 2007 | ₹0.55 M | Open |
Abn Amro Bank Nv Creation Date: 15 May 2007 | ₹5.00 M | Open |
How Many Employees Work at Aarushi Lithotripsy?
Unlock and access historical data on people associated with Aarushi Lithotripsy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarushi Lithotripsy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarushi Lithotripsy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
